Variant report
Variant | esv1839602 |
---|---|
Chromosome Location | chr8:130503150-130510068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr8:130504140-130504290 | NHEK | skin: | n/a | n/a |
2 | CUX1 | chr8:130505745-130505751 | GM12878 | blood: | n/a | n/a |
3 | E2F4 | chr8:130503920-130504016 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | E2F4 | chr8:130506077-130506083 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | GABPA | chr8:130510000-130514386 | HL-60 | blood: | n/a | n/a |
6 | GATA3 | chr8:130502635-130503194 | SK-N-SH | brain: | n/a | chr8:130502955-130502964 chr8:130502955-130502962 chr8:130503018-130503025 chr8:130502952-130502962 chr8:130502955-130502962 chr8:130503076-130503086 chr8:130502955-130502962 chr8:130502948-130502969 |
7 | MAX | chr8:130504256-130504268 | NB4 | blood: | n/a | n/a |
8 | MAX | chr8:130504149-130504442 | K562 | blood: | n/a | n/a |
9 | MEF2A | chr8:130502607-130503205 | SK-N-SH | brain: | n/a | chr8:130503076-130503084 chr8:130502943-130502957 |
10 | PBX3 | chr8:130502590-130503164 | SK-N-SH | brain: | n/a | n/a |
11 | POLR2A | chr8:130503295-130503799 | K562 | blood: | n/a | n/a |
12 | POLR2A | chr8:130506538-130506676 | K562 | blood: | n/a | n/a |
13 | POLR2A | chr8:130503527-130504546 | K562 | blood: | n/a | n/a |
14 | POLR2A | chr8:130504037-130504211 | K562 | blood: | n/a | n/a |
15 | POLR2A | chr8:130503776-130504065 | K562 | blood: | n/a | n/a |
16 | POLR2A | chr8:130504310-130504478 | K562 | blood: | n/a | n/a |
17 | POLR2A | chr8:130506344-130506349 | K562 | blood: | n/a | n/a |
18 | POLR2A | chr8:130504934-130505125 | K562 | blood: | n/a | n/a |
19 | POLR2A | chr8:130508821-130508984 | K562 | blood: | n/a | n/a |
20 | POLR2A | chr8:130506671-130507114 | K562 | blood: | n/a | n/a |
21 | POLR2A | chr8:130505806-130506047 | K562 | blood: | n/a | n/a |
22 | POLR2A | chr8:130505891-130505974 | K562 | blood: | n/a | n/a |
23 | POLR2A | chr8:130509476-130509554 | K562 | blood: | n/a | n/a |
24 | POLR2A | chr8:130505830-130506323 | K562 | blood: | n/a | n/a |
25 | POLR2A | chr8:130503765-130504456 | K562 | blood: | n/a | n/a |
26 | STAT3 | chr8:130505292-130505492 | MCF10A-Er-Src | breast: | n/a | chr8:130505481-130505492 |
27 | STAT3 | chr8:130507112-130507201 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | TCF12 | chr8:130502747-130503181 | SK-N-SH | brain: | n/a | n/a |
29 | TCF12 | chr8:130502589-130503211 | SK-N-SH | brain: | n/a | n/a |
30 | ZNF274 | chr8:130509726-130509949 | K562 | blood: | n/a | n/a |
31 | ZNF274 | chr8:130508519-130508728 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-3673 | chr8:130508099-130508119 | MIMAT0018096 |
hsa-miR-3669 | chr8:130509599-130509621 | MIMAT0018092 |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000265219 | TF binding region |
ENSG00000265687 | TF binding region |
ENSG00000266096 | TF binding region |
ENSG00000264680 | TF binding region |
ENSG00000266387 | TF binding region |
ENSG00000265513 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16904093 | chr8:130503150-130503151 | Enhancers Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs529232807 | chr8:130503218-130503219 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183600667 | chr8:130503219-130503220 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565699529 | chr8:130503248-130503249 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186197225 | chr8:130503268-130503269 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577802372 | chr8:130503406-130503407 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545169637 | chr8:130503423-130503424 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551080160 | chr8:130503462-130503463 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569374111 | chr8:130503486-130503487 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191021030 | chr8:130503511-130503512 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555974504 | chr8:130503523-130503524 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183543669 | chr8:130503530-130503531 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534269080 | chr8:130503538-130503539 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187936283 | chr8:130503619-130503620 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200043410 | chr8:130503656-130503657 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs578086112 | chr8:130503714-130503715 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545386684 | chr8:130503724-130503725 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147960268 | chr8:130503763-130503764 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563238732 | chr8:130503770-130503771 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575758483 | chr8:130503773-130503774 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544483461 | chr8:130503792-130503793 | Weak transcription Enhancers Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191240507 | chr8:130503816-130503817 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561956871 | chr8:130503926-130503927 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529061199 | chr8:130503928-130503929 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558117431 | chr8:130503967-130503968 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182659259 | chr8:130503972-130503973 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559189385 | chr8:130504038-130504039 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530482907 | chr8:130504045-130504046 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532776406 | chr8:130504082-130504083 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550918655 | chr8:130504099-130504100 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188136100 | chr8:130504156-130504157 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115004428 | chr8:130504208-130504209 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548789847 | chr8:130504212-130504213 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567877475 | chr8:130504215-130504216 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192779003 | chr8:130504239-130504240 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553643489 | chr8:130504285-130504286 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571928539 | chr8:130504298-130504299 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115439989 | chr8:130504346-130504347 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557434779 | chr8:130504395-130504396 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575698120 | chr8:130504405-130504406 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185202624 | chr8:130504412-130504413 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542338440 | chr8:130504490-130504491 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554739162 | chr8:130504513-130504514 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573796995 | chr8:130504550-130504551 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189127555 | chr8:130504619-130504620 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111634887 | chr8:130504628-130504629 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192124311 | chr8:130504651-130504652 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544894029 | chr8:130504676-130504677 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561597004 | chr8:130504756-130504757 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528796883 | chr8:130504759-130504760 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 22048815 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 21148746 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 20459607 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 22860045 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 16497871 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Cystic fibrosis | 19273617 | CNVD |
Chronic stroke | 19622162 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 17850661 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 16272173 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 16620391 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:130490200-130503400 | Weak transcription | Dnd41 | blood |
2 | chr8:130497200-130504200 | Weak transcription | Thymus | Thymus |
3 | chr8:130497600-130503600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr8:130500800-130503400 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr8:130502400-130503600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr8:130502400-130504600 | Enhancers | HMEC | breast |
7 | chr8:130502600-130503200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr8:130502600-130503400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr8:130502600-130503600 | Enhancers | NH-A | brain |
10 | chr8:130502600-130504200 | Enhancers | NHEK | skin |
11 | chr8:130502600-130504400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr8:130502800-130503400 | Enhancers | Osteobl | bone |
13 | chr8:130502800-130503600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr8:130502800-130504400 | Genic enhancers | K562 | blood |
15 | chr8:130503200-130504400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr8:130503400-130503800 | Strong transcription | Dnd41 | blood |
17 | chr8:130503600-130504400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr8:130503600-130519600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr8:130503800-130506200 | Weak transcription | Dnd41 | blood |
20 | chr8:130504200-130504400 | ZNF genes & repeats | Thymus | Thymus |
21 | chr8:130504400-130506800 | Strong transcription | K562 | blood |
22 | chr8:130506200-130507000 | ZNF genes & repeats | Dnd41 | blood |
23 | chr8:130506800-130507800 | ZNF genes & repeats | K562 | blood |
24 | chr8:130507000-130507600 | Strong transcription | Dnd41 | blood |
25 | chr8:130507600-130516400 | Weak transcription | Dnd41 | blood |
26 | chr8:130507800-130510600 | Weak transcription | K562 | blood |